Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naïve patients with chronic hepatitis: single-centre experience.
about
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistanceResistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical ImplicationsState of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationNS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in SpainClinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.
P2860
Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naïve patients with chronic hepatitis: single-centre experience.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Predominance of hepatitis C vi ...... tis: single-centre experience.
@en
type
label
Predominance of hepatitis C vi ...... tis: single-centre experience.
@en
prefLabel
Predominance of hepatitis C vi ...... tis: single-centre experience.
@en
P2093
P2860
P1433
P1476
Predominance of hepatitis C vi ...... tis: single-centre experience.
@en
P2093
Alex Proietti
Elisa Burdino
Giancarlo Orofino
Giovanni Di Perri
Lucio Boglione
Maria Grazia Milia
Stefano Bonora
Tina Ruggiero
Tiziano Allice
Valeria Ghisetti
P2860
P2888
P304
P356
10.1007/S00705-015-2563-3
P577
2015-08-07T00:00:00Z